HI
IBIO icon

Harbour Investments’s iBio IBIO Stock Holding History

Harbour Investments’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40
Closed -$161 – 3661
2025
Q1 		$161 Hold
40
– – ﹤0.01% 3437
2024
Q4 		$98 Hold
40
– – ﹤0.01% 3403
2024
Q3 		$89 Hold
40
– – ﹤0.01% 3321
2024
Q2 		$84 Hold
40
– – ﹤0.01% 3220
2024
Q1 		$162 Hold
40
– – ﹤0.01% 3125
2023
Q4 		$55 Hold
40
– – ﹤0.01% 3083
2023
Q3 		$243 Hold
40
– – ﹤0.01% 2868
2023
Q2 		$488 Hold
40
– – ﹤0.01% 2821
2023
Q1 		$1.66K Hold
40
– – ﹤0.01% 2597
2022
Q4 		$356 Buy
+40
New +$1.35K ﹤0.01% 2828
2021
Q4 		– Sell
-40
Closed -$21K – 3120
2021
Q3 		$21K Hold
40
– – ﹤0.01% 2270
2021
Q2 		$30K Hold
40
– – ﹤0.01% 2098
2021
Q1 		$31K Buy
+40
New +$34.8K ﹤0.01% 1949

Other funds holding IBIO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Harbour Investments's IBIO Position: Q2 2025 in Review

Harbour Investments sold out of iBio (IBIO) in Q2 2025, closing a stake of 40 shares — an estimated $161 sold.

Harbour Investments first reported a position in IBIO in Q1 2021 and held it in 13 quarters. The position peaked at $31K in Q1 2021. 30 funds tracked by Wall St. Rank hold IBIO as of Q2 2025.

  • Harbour Investments reported no remaining iBio position as of Q2 2025 after selling out during the quarter.
  • Harbour Investments sold 40 iBio shares in Q2 2025, an estimated $161.
  • Harbour Investments first reported a position in iBio in Q1 2021 and held it in 13 quarters.
  • Harbour Investments's iBio position peaked at $31K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held iBio as of Q2 2025.

Based on Harbour Investments's 13F filing for Q2 2025, filed 28 Jul 2025.